(NVEC) NVE - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US6294452064
NVEC: Sensors, Couplers, Convertors, Magnetoresistive Random Access Memory
NVE Corporation (NASDAQ:NVEC) specializes in the development and commercialization of spintronic devices, leveraging nanotechnology that utilizes electron spin for information processing. The company designs and manufactures a range of spintronic products, including sensors and couplers, which are integral to sensing and data transmission applications. These products serve diverse markets such as factory automation, medical devices, and industrial IoT (IIoT). The companys offerings include standard sensors for detecting magnetic or metallic materials, used in determining position, rotation, or speed in factory automation. Additionally, custom and medical sensors are designed to replace traditional electromechanical magnetic switches in medical devices. NVE also produces spintronic couplers for power conversion and IIoT applications, along with DC-to-DC converters for use in power conversion systems and industrial networks. The company engages in research and development contracts and licenses its spintronic magnetoresistive random access memory (MRAM) technology. NVEs products are distributed through a network of partners. Founded in 1989, the company is headquartered in Eden Prairie, Minnesota.
Over the next three months, NVE Corporations stock is expected to face headwinds. The stock is currently trading below its 20, 50, and 200-day moving averages, signaling bearish momentum. With an average true range (ATR) of 2.86, volatility is moderate, but the downward trend in moving averages suggests limited upside potential. Fundamentally, the companys high P/E ratio of 22.70 and P/B ratio of 5.60 indicate a premium valuation. The P/S ratio of 13.99 further highlights the stocks rich valuation relative to its sales. While the return on equity (RoE) of 23.80% reflects strong profitability, the current market sentiment and technical indicators point to a challenging environment for the stock in the near term. Investors should monitor the companys ability to maintain its profit margins and revenue growth to justify its valuation multiples.
Additional Sources for NVEC Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
NVEC Stock Overview
Market Cap in USD | 365m |
Sector | Technology |
Industry | Semiconductors |
GiC Sub-Industry | Semiconductors |
IPO / Inception | 1996-09-26 |
NVEC Stock Ratings
Growth 5y | 42.7% |
Fundamental | 38.4% |
Dividend | 42.0% |
Rel. Strength Industry | -18.4 |
Analysts | - |
Fair Price Momentum | 59.14 USD |
Fair Price DCF | 51.07 USD |
NVEC Dividends
Dividend Yield 12m | 5.69% |
Yield on Cost 5y | 10.65% |
Annual Growth 5y | 0.00% |
Payout Consistency | 38.3% |
NVEC Growth Ratios
Growth Correlation 3m | -74.2% |
Growth Correlation 12m | -19.2% |
Growth Correlation 5y | 80.6% |
CAGR 5y | 11.34% |
CAGR/Max DD 5y | 0.28 |
Sharpe Ratio 12m | -0.54 |
Alpha | -28.81 |
Beta | 1.27 |
Volatility | 35.44% |
Current Volume | 17k |
Average Volume 20d | 20.1k |
As of March 14, 2025, the stock is trading at USD 64.29 with a total of 16,995 shares traded.
Over the past week, the price has changed by -3.35%, over one month by -11.87%, over three months by -16.43% and over the past year by -19.47%.
Partly, yes. Based on ValueRay Fundamental Analyses, NVE (NASDAQ:NVEC) is currently (March 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 38.39 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NVEC as of March 2025 is 59.14. This means that NVEC is currently overvalued and has a potential downside of -8.01%.
NVE has no consensus analysts rating.
According to ValueRays Forecast Model, NVEC NVE will be worth about 67.5 in March 2026. The stock is currently trading at 64.29. This means that the stock has a potential upside of +5.01%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 79 | 22.9% |
Analysts Target Price | 79 | 22.9% |
ValueRay Target Price | 67.5 | 5% |